Science & Enterprise subscription

Follow us on Twitter

  • National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
    about 21 hours ago
  • New post on Science and Enterprise: NSF Funds AI Covid-19 Drug Combo Simulation https://t.co/j7DsIncCUk #Science #Business
    about 21 hours ago
  • A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for… https://t.co/CVwEr6dEoU
    about 21 hours ago
  • New post on Science and Enterprise: Gene-Edited Transplant Organ Company Raises $125M https://t.co/UYlUcA8Z5X #Science #Business
    about 1 day ago
  • A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-1… https://t.co/82gYsU3rvr
    about 2 days ago

Please share Science & Enterprise

Diagnostic Cleared for Covid-19, Other Diseases

Amplidiag Easy system

A single diagnostic test for the virus causing Covid-19 infections and three other respiratory diseases received clearance for marketing in Europe. . . . → Read More: Diagnostic Cleared for Covid-19, Other Diseases

Trial Shows Home Mosquito Device Cuts Malaria Cases

EaveTube device

A clinical trial shows homes installed with devices that attract then kill mosquitos have fewer malaria cases than homes with standard preventions. . . . → Read More: Trial Shows Home Mosquito Device Cuts Malaria Cases

New Trial Testing Reformulated Covid-19 Vaccine

Panama City skyline

Two drug makers are beginning a clinical trial to test their reformulated vaccine against Covid-19 disease, particularly among older populations. . . . → Read More: New Trial Testing Reformulated Covid-19 Vaccine

Novartis, Gates Partner on Sickle Cell Gene Therapy

Gene therapy graphic

Global drug maker Novartis is collaborating with the Bill and Melinda Gates Foundation to find affordable gene therapies for sickle cell disease. . . . → Read More: Novartis, Gates Partner on Sickle Cell Gene Therapy

Immune Response Shown in Alzheimer’s Vaccine

Brain activity graphic

Results from a clinical trial show an experimental vaccine produces antibodies for breaking up harmful brain deposits in people with early Alzheimer’s disease. . . . → Read More: Immune Response Shown in Alzheimer’s Vaccine

Biotech, UK Govt to Design Covid-19 Variant Vaccines

Vaccine vials

A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations. . . . → Read More: Biotech, UK Govt to Design Covid-19 Variant Vaccines

Cannabidiol Drug Maker Acquired in $7.2B Deal

Cannabis plant

A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal. . . . → Read More: Cannabidiol Drug Maker Acquired in $7.2B Deal

Covid-19 Vaccine Shown Safe, Effective in Russian Test

Red Square, Moscow

Interim results from a clinical trial in Russia of a two-dose vaccine show a high efficacy rate in preventing Covid-19 disease and few serious adverse effects. . . . → Read More: Covid-19 Vaccine Shown Safe, Effective in Russian Test

Institutions Join Global Health Breakthrough Network

Networked earth

Wellcome Leap aims to establish a model for faster design and development of health breakthroughs, beginning with elimination of administrative obstacles. . . . → Read More: Institutions Join Global Health Breakthrough Network

Food Allergy Biotech Raises $40M in New Funds

bread and rolls

A biotechnology company designing proteins in food products and therapies for people with food allergies is raising $40 million in its second venture round. . . . → Read More: Food Allergy Biotech Raises $40M in New Funds